These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36368348)

  • 21. Current Use of Hearts From Hepatitis C Viremic Donors.
    Moayedi Y; Fan CPS; Gulamhusein AF; Manlhiot C; Ross HJ; Teuteberg JJ; Khush KK
    Circ Heart Fail; 2018 Dec; 11(12):e005276. PubMed ID: 30562093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study.
    Franco A; Moreso F; Merino E; Sancho A; Kanter J; Gimeno A; Balibrea N; Rodriguez M; Perez Contreras F
    Transpl Int; 2019 Jul; 32(7):710-716. PubMed ID: 30773693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.
    Bethea ED; Gaj K; Gustafson JL; Axtell A; Lebeis T; Schoenike M; Turvey K; Coglianese E; Thomas S; Newton-Cheh C; Ibrahim N; Carlson W; Ho JE; Shah R; Nayor M; Gift T; Shao S; Dugal A; Markmann J; Elias N; Yeh H; Andersson K; Pratt D; Bhan I; Safa K; Fishman J; Kotton C; Myoung P; Villavicencio MA; D'Alessandro D; Chung RT; Lewis GD
    Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):771-780. PubMed ID: 31353243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of HCV-Positive Livers in HCV-Negative Recipients.
    Thuluvath PJ; Bruno DA; Alukal J; Satapathy SK; Thuluvath AJ; Zhang T
    Am J Gastroenterol; 2020 Jul; 115(7):1045-1054. PubMed ID: 32618655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mid-term Waitlist and Posttransplant Outcomes With Hepatitis C-positive Donor Hearts.
    Hong Y; Couper CD; Iyanna N; Hess NR; Ziegler LA; Abdullah M; Mathier MA; Hickey GW; Keebler ME; Silvestry SC; Kaczorowski D
    Transplantation; 2024 Sep; ():. PubMed ID: 39228015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation.
    Da BL; Ezaz G; Kushner T; Crismale J; Kakked G; Gurakar A; Dieterich D; Schiano TD; Saberi B
    JAMA Netw Open; 2020 Dec; 3(12):e2027551. PubMed ID: 33275155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.
    Bari K; Luckett K; Kaiser T; Diwan T; Cuffy M; Schoech MR; Safdar K; Blackard JT; Apewokin S; Paterno F; Sherman KE; Zucker SD; Anwar N; Shah SA
    Hepatology; 2018 May; 67(5):1673-1682. PubMed ID: 29205441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C-positive donor to negative recipient kidney transplantation: A real-world experience.
    Jandovitz N; Nair V; Grodstein E; Molmenti E; Fahmy A; Abate M; Bhaskaran M; Teperman L
    Transpl Infect Dis; 2021 Jun; 23(3):e13540. PubMed ID: 33259125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.
    Kapila N; Menon KVN; Al-Khalloufi K; Vanatta JM; Murgas C; Reino D; Ebaid S; Shaw JJ; Agrawal N; Rhazouani S; Navas V; Sheffield C; Rahman AU; Castillo M; Lindenmeyer CC; Miller C; Quintini C; Zervos XB
    Hepatology; 2020 Jul; 72(1):32-41. PubMed ID: 31659775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac transplantation from non-viremic hepatitis C donors.
    Patel SR; Madan S; Saeed O; Sims DB; Shin JJ; Nucci C; Borukhov E; Goldstein DY; Jakobleff W; Forest S; Vukelic S; Murthy S; Reinus J; Puius Y; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2018 Oct; 37(10):1254-1260. PubMed ID: 30126825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor.
    Stepanova M; Sayiner M; de Avila L; Younoszai Z; Racila A; Younossi ZM
    BMC Gastroenterol; 2016 Nov; 16(1):137. PubMed ID: 27846801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
    Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rise of the opioid epidemic and hepatitis C-positive organs: A new era in liver transplantation.
    Gonzalez SA; Trotter JF
    Hepatology; 2018 Apr; 67(4):1600-1608. PubMed ID: 29023920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor hepatitis C antibody positivity misclassifies kidney donor profile index in non-hepatitis C-infected donors: time to revise the kidney donor profile index - a retrospective cohort study.
    Yazawa M; Balaraman V; Tsujita M; Azhar A; Talwar M; Bhalla A; Potukuchi PK; Eason JD; Kovesdy CP; Molnar MZ
    Transpl Int; 2020 Dec; 33(12):1732-1744. PubMed ID: 32935416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of donor and recipient hepatitis C status in lung transplantation.
    Englum BR; Ganapathi AM; Speicher PJ; Gulack BC; Snyder LD; Davis RD; Hartwig MG
    J Heart Lung Transplant; 2016 Feb; 35(2):228-35. PubMed ID: 26615769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor and Recipient Hepatitis C Status Does Not Affect Rejection in Thoracic Transplantation.
    Ganapathi AM; Whitson BA; Heh V; Keller BC; Smith SA; Mokadam NA; Henn MC
    Ann Thorac Surg; 2023 Jan; 115(1):221-230. PubMed ID: 35940315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.